Skip to content

PHARMA GONRIEUX

Active Private limited companyfounded 2018active for 8 yearsRue Jean-Chot, Olloy 72, 5670 ViroinvalKBO/BCE: BE 0697.833.935

Lifetime

7 annual accounts with figures on one time axis
peak of €423,909 in 2019
€261,102▲ 71.3%
lowest -€2,280 in 2023
€56,436▲ 372×
peak of €316,532 in 2025
€316,532▲ 19.4%
€413,643▼ 21.9%
peak of 2 FTE in 2020
1.8 FTE▲ 12.5%
Board2 names since 2018
2 directors and 1 other
Documentsfilings and deeds
28-08-202628 days late
2025abbreviated format
Gross margin from €152,443 to €261,102Result from €152 to €56,436Staff from 1.6 FTE to 1.8 FTEEquity from €265,096 to €316,532Debts from €529,400 to €413,643

Key points

from the 2025 annual accounts

Result

€56,436 ▲ 372×
€1522024€56,4002025

The result rose in 2025: mostly from a one-off income of €70,036.

Staff

2 employees on 31-12-2025
012022432023012024212025

In 2025, 2 employees joined and 1 left.

Filings

7 annual accounts 7 late
AprilJune31 JulyOctober202020222024

The 2019 accounts came in latest, 87 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,972 companies had the same profile as PHARMA GONRIEUX has now. Each dot stands for 68 companies, two years later.

94.9%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,972 companies, not a prediction for PHARMA GONRIEUX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
  • 50 sharesdeed of 21-06-2018
  • 50 sharesdeed of 21-06-2018
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0697833935
(director) and (director) change roles acts as permanent representative · “La société a pour objet en tout endroit de la Communauté Européenne et partout ailleurs dans le Monde entier…” (deed in French) · General meeting of 18-12-2023 · Gazette deed
First establishment Place Dr-Charles-Briquet, Gon. 3, Couvin
Incorporation Founding capital of €18,600, 100 shares · Founded by and · (manager) and (manager) appointed · published on 21-06-2018 · Gazette deed
All 15 events

Comparable companies

same main activity, similar in size and age
Company
PHARMA GONRIEUX Viroinval €730,175 €261,102 43.4% 1.8
APOTHEEK BOLLEN Aarschot €688,724 €256,866 66.8% 1.8
PHARMATRUST Anderlecht €716,875 €267,918 56.0% 1.6
PHARMAZINNES Namur €875,224 €231,990 13.9% 1.5
PROXY PHARMA Beauvechain €752,890 €214,043 2.9% 1.8
APOTHEEK MEES GEETBETS Geetbets €777,058 €307,519 26.3% 2.3
Pharma Petite Suisse Ixelles €776,775 €314,507 5.4% 2.3

These companies have the same main activity as PHARMA GONRIEUX: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €689,000 and €875,000, founded between 2017 and 2019.

Official details

Source: KBO
Status
Active since 12-06-2018Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.276.751.9305660 Couvin, since 01-07-2018
Financial year end
31 December
Peppol
Reachable since 01-12-2025
Company details

Annual accounts 2025

≈ €900,000estimated
€730,175▼ 8.1%
Employeeson 31-12-2025
2▲ 100%
Filing
Filed on 28-08-2026
Financials

Insights on PHARMA GONRIEUX

PHARMA GONRIEUX files the abbreviated format. That format states no turnover. The gross margin fell from €423,909 in 2019 to €261,102 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARMA GONRIEUX

What is the company number of PHARMA GONRIEUX?
The company number of PHARMA GONRIEUX is 0697.833.935. The VAT number is the same number with BE in front: BE 0697.833.935.
Where is PHARMA GONRIEUX based?
The registered office is at Rue Jean-Chot, Olloy 72, 5670 Viroinval.Company details
What does PHARMA GONRIEUX do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMA GONRIEUX?
PHARMA GONRIEUX is a private limited company (BV).
When was PHARMA GONRIEUX founded?
PHARMA GONRIEUX was founded on 12-06-2018.
Is PHARMA GONRIEUX still active?
Yes, PHARMA GONRIEUX is an active enterprise in the KBO register.
How many employees does PHARMA GONRIEUX have?
PHARMA GONRIEUX had an average of 1.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of PHARMA GONRIEUX?
The turnover in financial year 2025 is about €900,000. This figure is estimated from the gross margin of €261,102 and 42 comparable companies (NACE 477). It probably lies between €710,000 and €1.2m.
Is PHARMA GONRIEUX profitable?
In financial year 2025, PHARMA GONRIEUX made a profit of €56,436.
Where can I find the annual accounts of PHARMA GONRIEUX?
PHARMA GONRIEUX filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMA GONRIEUX due?
PHARMA GONRIEUX must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.